We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$2.19B
AUM Growth
+$209M
Cap. Flow
+$49.6M
Cap. Flow %
2.27%
Top 10 Hldgs %
52.18%
Holding
33
New
1
Increased
24
Reduced
8
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$8.75M
2
QCOM icon
Qualcomm
QCOM
+$7.24M
3
EL icon
Estee Lauder
EL
+$6.02M
4
BIIB icon
Biogen
BIIB
+$5.55M
5
EMC
EMC CORPORATION
EMC
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 30.23%
2 Consumer Discretionary 24.87%
3 Technology 24.51%
4 Consumer Staples 10.1%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXF icon
26
Vanguard Extended Market ETF
VXF
$30.5B
$566K 0.03%
6,451
-35
-0.5% -$3K
XLP icon
27
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$524K 0.02%
10,816
-107
-1% -$5.06K
IGSB icon
28
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$503K 0.02%
9,558
+188
+2% +$9.9K
AAXJ icon
29
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
$357K 0.02%
5,851
+23
+0.4% +$1.41K
IWV icon
30
iShares Russell 3000 ETF
IWV
$19.6B
$134K 0.01%
1,095
-89
-8% -$10.6K
LQD icon
31
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$102K ﹤0.01%
853
+16
+2% +$1.91K
JNK icon
32
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
$84.4K ﹤0.01%
728
+26
+4% +$3.08K
IVV icon
33
iShares Core S&P 500 ETF
IVV
$881B
$74.7K ﹤0.01%
+361
New +$73.1K

Similar funds

WestEnd Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, WestEnd Advisors held 33 positions worth $2.19B, up 11% from $1.98B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 3%. WestEnd Advisors opened 1 new position and made no exits, leaving the 33-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

  • WestEnd Advisors's largest Q4 2014 buy was iShares Core S&P 500 ETF: 361 shares worth $74.7K.
  • WestEnd Advisors added most to Gilead Sciences in Q4 2014, an estimated $8.75M increase.
  • WestEnd Advisors's biggest Q4 2014 reduction was Celgene Corp, cutting an estimated $4.84M.
  • WestEnd Advisors's ten largest holdings make up 52% of its $2.19B portfolio in Q4 2014.
  • WestEnd Advisors opened 1 new position and closed 0 in Q4 2014.
  • WestEnd Advisors's portfolio value rose 11% quarter-over-quarter to $2.19B.

Based on WestEnd Advisors's 13F filing for Q4 2014, filed 5 Feb 2015.